Home/Filings/4/0001415889-24-016510
4//SEC Filing

Stevens Raymond C 4

Accession 0001415889-24-016510

CIK 0001888886other

Filed

Jun 11, 8:00 PM ET

Accepted

Jun 12, 4:42 PM ET

Size

12.0 KB

Accession

0001415889-24-016510

Insider Transaction Report

Form 4
Period: 2024-06-10
Stevens Raymond C
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Conversion

    American Depositary Shares

    2024-06-10+185,000185,000 total
    Ordinary Shares (555,000 underlying)
  • Conversion

    Ordinary Shares

    2024-06-10555,000643,346 total
  • Sale

    American Depositary Shares

    2024-06-10$52.80/sh185,000$9,767,3530 total
    Ordinary Shares (555,000 underlying)
Holdings
  • American Depositary Shares

    (indirect: See footnote)
    Ordinary Shares (12,000 underlying)
    4,000
  • Ordinary Shares

    (indirect: See footnote)
    1,554,586
Footnotes (4)
  • [F1]The Ordinary Shares were converted into American Depositary Shares as reported in Table II above.
  • [F2]By Raymond Stevens and Vivian Urena-Stevens, as Co-Trustees of the Stevens 2001 Revocable Trust, dated March 28, 2001.
  • [F3]Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.
  • [F4]The weighted average sale price for the transaction was $52.7965, and the range of prices was $52.43 and $53.075. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Issuer

Structure Therapeutics Inc.

CIK 0001888886

Entity typeother

Related Parties

1
  • filerCIK 0001698149

Filing Metadata

Form type
4
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:42 PM ET
Size
12.0 KB